Cronos (CRON) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $3.21, +0.31% vs the prior close of $3.20.
- Volume 863.32K shares, 0.7x its 50-day average.
- New SEC filings: 8-K (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
CRON rises 0.3% to $3.21. Closed at $3.21, +0.31% vs the prior close of $3.20. Day range $3.20–$3.36, opened at $3.22.
CRON daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — CRON rises 0.3% to $3.21
- Closed at $3.21, +0.31% vs the prior close of $3.20. Day range $3.20–$3.36, opened at $3.22.
- Volume was 863.32K shares, 0.7x its 50-day average of 1.18M.
- Price is -1.7% vs its 50-day average ($3.26) and +13.8% vs its 200-day average ($2.82).
- 52-week range $2.28–$3.61; today's close sits at 70% of that range, 11.0% below the 52-week high.
Oct 15, 2026 — CRON rises 1.3% to $3.20
- Closed at $3.20, +1.27% vs the prior close of $3.16. Day range $3.17–$3.26, opened at $3.17.
- Volume was 807.70K shares, 0.7x its 50-day average of 1.20M.
- Price is -1.9% vs its 50-day average ($3.26) and +13.6% vs its 200-day average ($2.82).
- 52-week range $2.28–$3.61; today's close sits at 69% of that range, 11.3% below the 52-week high.
- SEC filings that day: 8-K.
Oct 14, 2026 — CRON dips 1.2% to $3.16, a 1-month low, 3 down days in a row
- Closed at $3.16, -1.25% vs the prior close of $3.20. Day range $3.15–$3.22, opened at $3.17.
- Volume was 954.70K shares, 0.8x its 50-day average of 1.21M.
- Price is -2.8% vs its 50-day average ($3.25) and +12.3% vs its 200-day average ($2.81).
- 52-week range $2.28–$3.61; today's close sits at 66% of that range, 12.4% below the 52-week high.
- That makes 3 straight losses.
Oct 13, 2026 — CRON dips 0.3% to $3.20
- Closed at $3.20, -0.31% vs the prior close of $3.21. Day range $3.18–$3.25, opened at $3.21.
- Volume was 515.40K shares, 0.4x its 50-day average of 1.22M — lighter than usual.
- Price is -1.4% vs its 50-day average ($3.24) and +13.8% vs its 200-day average ($2.81).
- 52-week range $2.28–$3.61; today's close sits at 69% of that range, 11.3% below the 52-week high.
Oct 12, 2026 — CRON dips 0.6% to $3.21
- Closed at $3.21, -0.62% vs the prior close of $3.23. Day range $3.20–$3.23, opened at $3.22.
- Volume was 687.10K shares, 0.6x its 50-day average of 1.22M — lighter than usual.
- Price is -0.8% vs its 50-day average ($3.24) and +14.2% vs its 200-day average ($2.81).
- 52-week range $2.28–$3.61; today's close sits at 70% of that range, 11.0% below the 52-week high.
Oct 9, 2026 — CRON rises 0.3% to $3.23
- Closed at $3.23, +0.31% vs the prior close of $3.22. Day range $3.21–$3.23, opened at $3.23.
- Volume was 414.00K shares, 0.3x its 50-day average of 1.23M — lighter than usual.
- Price is +0.0% vs its 50-day average ($3.23) and +15.1% vs its 200-day average ($2.81).
- 52-week range $2.28–$3.61; today's close sits at 72% of that range, 10.5% below the 52-week high.
Oct 8, 2026 — CRON dips 0.6% to $3.22
- Closed at $3.22, -0.62% vs the prior close of $3.24. Day range $3.15–$3.23, opened at $3.22.
- Volume was 974.20K shares, 0.8x its 50-day average of 1.23M.
- Price is -0.1% vs its 50-day average ($3.22) and +14.8% vs its 200-day average ($2.81).
- 52-week range $2.28–$3.61; today's close sits at 71% of that range, 10.8% below the 52-week high.
Oct 7, 2026 — CRON dips 1.4% to $3.24
- Closed at $3.24, -1.37% vs the prior close of $3.29. Day range $3.24–$3.30, opened at $3.26.
- Volume was 455.90K shares, 0.4x its 50-day average of 1.24M — lighter than usual.
- Price is +0.7% vs its 50-day average ($3.22) and +15.6% vs its 200-day average ($2.80).
- 52-week range $2.28–$3.61; today's close sits at 72% of that range, 10.2% below the 52-week high.
Oct 6, 2026 — CRON rises 1.1% to $3.29, 3 up days in a row
- Closed at $3.29, +1.08% vs the prior close of $3.25. Day range $3.24–$3.30, opened at $3.26.
- Volume was 677.80K shares, 0.5x its 50-day average of 1.24M — lighter than usual.
- Price is +2.4% vs its 50-day average ($3.21) and +17.2% vs its 200-day average ($2.80).
- 52-week range $2.28–$3.61; today's close sits at 76% of that range, 9.0% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — CRON rises 0.8% to $3.25
- Closed at $3.25, +0.78% vs the prior close of $3.22. Day range $3.23–$3.32, opened at $3.23.
- Volume was 1.22M shares, 1.0x its 50-day average of 1.24M.
- Price is +1.6% vs its 50-day average ($3.20) and +16.0% vs its 200-day average ($2.80).
- 52-week range $2.28–$3.61; today's close sits at 73% of that range, 9.9% below the 52-week high.
Oct 2, 2026 — CRON rises 0.5% to $3.22
- Closed at $3.22, +0.47% vs the prior close of $3.21. Day range $3.19–$3.28, opened at $3.25.
- Volume was 1.24M shares, 1.0x its 50-day average of 1.24M.
- Price is +1.1% vs its 50-day average ($3.19) and +15.1% vs its 200-day average ($2.80).
- 52-week range $2.28–$3.61; today's close sits at 71% of that range, 10.6% below the 52-week high.
CRON latest news & SEC filings
Every SEC filing by or about CRON in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 2.01 — Completed an acquisition or sale of assets.
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 11, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 7, 2026 · Form 8-K/A — Current report (amended)
Amended current report
- Item 5.07 — Reported shareholder vote results.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $53.01M (prior year $33.45M) (+58.4% vs Jun 30, 2025)
- Net income: $32.09M (prior year -$39.71M) (swung to profit vs Jun 30, 2025)
- Diluted EPS: $0.09 (prior year -$0.10) (swung to profit vs Jun 30, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jun 30, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jun 22, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Things to know before you trade CRON
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Feb 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.19% (largest 3.0%).
- Liquidity: about 859.36K shares (≈$2.76M) trade per day on average.
- 52-week position: $3.21 vs a range of $2.28–$3.61 (70% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 15, 2026; 8-K Sep 11, 2026; 10-Q Aug 6, 2026.
- Share count: 368.41M shares outstanding (Aug 3, 2026), -3.8% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Medicinal Chemicals & Botanical Products.
CRON market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.22 | 3.36 | 3.20 | 3.21 | 863.32K |
| Oct 15, 2026 | 3.17 | 3.26 | 3.17 | 3.20 | 807.70K |
| Oct 14, 2026 | 3.17 | 3.22 | 3.15 | 3.16 | 954.70K |
| Oct 13, 2026 | 3.21 | 3.25 | 3.18 | 3.20 | 515.40K |
| Oct 12, 2026 | 3.22 | 3.23 | 3.20 | 3.21 | 687.10K |
| Oct 9, 2026 | 3.23 | 3.23 | 3.21 | 3.23 | 414.00K |
| Oct 8, 2026 | 3.22 | 3.23 | 3.15 | 3.22 | 974.20K |
| Oct 7, 2026 | 3.26 | 3.30 | 3.24 | 3.24 | 455.90K |
| Oct 6, 2026 | 3.26 | 3.30 | 3.24 | 3.29 | 677.80K |
| Oct 5, 2026 | 3.23 | 3.32 | 3.23 | 3.25 | 1.22M |
| Oct 2, 2026 | 3.25 | 3.28 | 3.19 | 3.22 | 1.24M |
| Oct 1, 2026 | 3.27 | 3.30 | 3.21 | 3.21 | 1.32M |
| Sep 30, 2026 | 3.37 | 3.38 | 3.25 | 3.30 | 1.82M |
| Sep 29, 2026 | 3.42 | 3.43 | 3.37 | 3.38 | 762.00K |
| Sep 28, 2026 | 3.31 | 3.45 | 3.29 | 3.41 | 1.13M |
| Sep 25, 2026 | 3.32 | 3.35 | 3.25 | 3.34 | 876.50K |
| Sep 24, 2026 | 3.40 | 3.42 | 3.32 | 3.32 | 721.20K |
| Sep 23, 2026 | 3.45 | 3.45 | 3.38 | 3.40 | 512.80K |
| Sep 22, 2026 | 3.34 | 3.46 | 3.34 | 3.43 | 766.80K |
| Sep 21, 2026 | 3.35 | 3.39 | 3.31 | 3.33 | 472.00K |
About Cronos
Cronos (CRON) is listed on the Nasdaq and classified by the SEC under “Medicinal Chemicals & Botanical Products”. Its business address is in STAYNER, Ontario, Canada. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1656472.
CRON board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Jason Marc Adler | Director | Aug 7, 2026 |
| Darren Chester Broughton | Director | Jun 30, 2026 |
| Michael Ryan Gorenstein | See remarks below | Mar 17, 2026 |
| Murray R Garnick | Director | Aug 7, 2026 |
| James Daniel Rudyk | Director | Aug 7, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Shannon Buggy | See Remarks | May 14, 2026 |
| Terrence Gregory Joseph Doucet | See Remarks | May 14, 2026 |
| Michael Ryan Gorenstein | See remarks below | Mar 17, 2026 |
| Jeffrey David Jacobson | Chief Growth Officer | Mar 17, 2026 |
| Jared Matthew Kenost | See Remarks | May 14, 2026 |
| Anna Shlimak | See Remarks | Mar 20, 2026 |
| Adam Wagner | See remarks | May 14, 2026 |
| Arye Weigensberg | See Remarks | May 12, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
CRON financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $146.59M | $-9.45M | -0.02 | $25.87M |
| Dec 31, 2024 | $117.61M | $41.08M | 0.11 | $18.84M |
| Dec 31, 2023 | $87.24M | $-73.96M | -0.19 | $-42.84M |
| Dec 31, 2022 | $86.75M | $-168.73M | -0.45 | $-88.95M |
| Dec 31, 2021 | $64.56M | $-396.11M | -1.07 | $-153.62M |
Latest balance sheet: total assets $1.18B, total liabilities $62.41M, cash $467.02M (as of Jun 30, 2026).
CRON earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $3.07 |
| May 11, 2026 | 8-K Item 2.02 (results) | $2.75 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $2.67 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $2.47 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $2.27 |
| May 8, 2025 | 8-K Item 2.02 (results) | $2.00 |
| Feb 27, 2025 | 8-K Item 2.02 (results) | $2.00 |
| Nov 12, 2024 | 8-K Item 2.02 (results) | $2.26 |
| Aug 8, 2024 | 8-K Item 2.02 (results) | — |
| May 9, 2024 | 8-K Item 2.02 (results) | — |
| Feb 29, 2024 | 8-K Item 2.02 (results) | — |
| Nov 8, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Medicinal Chemicals & Botanical Products
Definium Therapeutics (DFTX)Trulieve Cannabis (TRLV)Tilray Brands (TLRY)IM Cannabis (IMCC)Glass House Brands (GLAS)Aurora Cannabis (ACB)Usana Health Sciences (USNA)Regencell Bioscience (RGC)Canopy Growth (CGC)Sndl (SNDL)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on CRON
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.